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As many countries in Europe make progress in tubercu-
losis (TB) control, TB incidence in Europe is diverse; in 
low-incidence countries (those with an incidence less 
than 20 per 100,000 [1]) the TB burden is increasingly 
borne by specific risk groups, such as migrants from 
high- to lower-incidence countries, persons with social 
risk factors such as homelessness and individuals who 
have been in contact with a TB patient. Strategies to 
control TB within these risk groups include screening 
for active disease and sometimes latent infection [2,3], 
followed by treatment where appropriate. The effec-
tiveness of screening strategies to identify patients 
needing treatment varies. For example, the yield of 
active TB among migrants from high- to low-burden 
countries ranged from 7 to 10,186 per 100,000 people 
screened, depending on various factors including the 
TB prevalence in the country of origin [2]. In this World 
TB Day issue of Eurosurveillance, four papers describe 
the risks of TB infection and disease in two potentially 
high-risk groups: migrants [4,5] and airline passengers 
[6,7].
Migrants are considered to be at high risk of TB, for 
reasons such as the possibility of reactivation of latent 
infection acquired in their home country, frequent 
travel to high-incidence areas, and perhaps transmis-
sion within migrant communities in the receiving coun-
tries [8]. At European Union (EU) level, Hollo et al. report 
that TB rates are higher, and declining more slowly, in 
individuals not native to the reporting countries com-
pared with the native population [4]. This highlights 
important health inequalities and major challenges to 
the control of TB, while it also illustrates difficulties in 
combining data from multiple countries. Besides differ-
ences in the definition of TB cases of ‘foreign origin’ 
between countries, several points complicate interpre-
tation of these data. Migrants constitute a heterogene-
ous group of individuals from multiple countries and 
with varying risk factor profiles, thus simply being ‘for-
eign born’ is not necessarily a good proxy for having a 
high risk of TB infection or disease, and particular risk 
factor profiles may be more common in some countries 
than in others, e.g. due to differences in migration pat-
terns. The implications of migration for TB incidence 
thus depend on detailed patterns of migration [9]. 
There is therefore a need to further investigate, at 
country level, risk factors for TB in migrants and to fur-
ther elucidate detailed migration and travel patterns 
and develop tailored solutions specific to the epidemic 
affecting each group [10].
Addressing the needs of a specific group of migrants, 
namely asylum seekers, Bozorgmehr and colleagues 
systematically review the yield of upon-entry screen-
ing for active TB of asylum seekers entering Germany, 
a low-incidence country [5]. Like many European coun-
tries, Germany sees a higher rate of TB among foreign-
born compared with native-born individuals. Pooling 
results from the six diverse studies included in the 
review, the authors report that 3.47 cases of active TB 
were identified per 1,000 asylum seekers screened. 
However, there was substantial heterogeneity between 
studies, and the authors highlight the need to under-
stand reasons for this variation. Explanations might 
include differences in study populations e.g. countries 
of origin, age distribution, prevalence of co-morbidities, 
case definitions and diagnostic methods. Furthermore, 
cost-effectiveness of screening approaches including 
cost per quality-adjusted life year should inform the 
selection of screening methods and the prioritisation 
of populations.
Arguably more controversial than screening migrants is 
the issue of screening individuals exposed to patients 
with active TB on board aircraft. While the World 
Health Organization (WHO) and European Centre for 
Disease Prevention and Control (ECDC) recommend 
contact investigations among passengers seated 
within two rows of an infectious case on flights last-
ing 8 hours or longer [11,12], both organisations and 
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others [13] acknowledge that there is only limited 
evidence to quantify the risk of transmission on air-
craft. Two papers in this issue discuss screening of 
airline contacts for latent TB infection (LTBI): one is 
an intensive contact investigation following a fatal 
case of extensively drug-resistant (XDR)-TB [7], while 
the other reports the overall yield based on multiple 
investigations conducted in Japan [6]. Both report 
very low yields. The XDR-TB study included tuberculin 
skin tests (TST) and interferon gamma release assays 
(IGRAs) within 8 weeks from exposure and at least 8 
weeks after exposure. One case of possible transmis-
sion (TST conversion) from the XDR-TB patient occurred 
among 112 people screened for LTBI. An additional 14 
people had LTBI, however, and recent transmission 
could be neither established nor ruled out, due to the 
absence of baseline test results. The Japanese study 
reported that, of 651 contacts meeting the WHO criteria 
for investigation, 25 (3.8%) had a positive IGRA result, 
but data on conversions were not available. Neither 
study identified any cases of active TB resulting from 
onboard transmission.
Difficulties inherent in TB epidemiology, particularly in 
distinguishing recent from earlier infection, complicate 
the interpretation of findings from contact investiga-
tions in general. Dealing with the diverse and likely 
geographically dispersed contacts in airline exposures 
presents additional challenges. Data on TST or IGRA 
conversions, indicating recent infection, would help to 
better quantify the risk of transmission following expo-
sure on an airplane, but conducting repeat tests among 
passengers (who may subsequently leave the investi-
gating country) would be logistically difficult. However, 
the low prevalence of positivity reported in these and 
other studies suggests that the risk of transmission 
may be low, suggesting that other TB control interven-
tions might be prioritised over exposed air passenger 
screening. However, even in the absence of solid evi-
dence of the benefit of screening air passenger con-
tacts of active TB, and especially in situations which 
appear to pose a particularly high-risk, a precautionary 
approach may be adopted. This was part of the ration-
ale for investigating the apparently dramatic XDR-TB 
incident despite a relatively short flight duration [7].
Although screening for active TB and LTBI is generally 
considered worthwhile, the four studies presented 
in this issue illustrate that substantial uncertainty 
remains regarding the best ways to implement screen-
ing. Critically, screening of any population is only ben-
eficial if a positive result leads to effective action. 
Therefore robust systems must be in place to enable 
those with a positive result to access and complete 
treatment. Effectiveness and cost-effectiveness of 
strategies targeting different populations and using 
different diagnostic tests need to be assessed in the 
context of local TB epidemiology – and should account 
not only for the direct benefits of identifying and treat-
ing cases, but also for the reductions in incidence 
achieved by preventing onward transmission. As the 
movement of people, including those with TB, becomes 
increasingly common, approaches to TB control need 
to become correspondingly international. Cooperation 
within the EU and the wider international community is 
essential if we are to successfully control the disease.
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